Krysta Coyle
Krysta Coyle
Verified email at
Cited by
Cited by
GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults
H Behzad, ALW Huckriede, L Haynes, B Gentleman, K Coyle, JC Wilschut, ...
Journal of Infectious Diseases 205 (3), 466-473, 2012
Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling
P Marcato, CA Dean, RZ Liu, KM Coyle, M Bydoun, M Wallace, ...
Molecular oncology 9 (1), 17-31, 2015
Mast cell and eosinophil activation are associated with COVID-19 and TLR-mediated viral inflammation: implications for an anti-Siglec-8 antibody
S Gebremeskel, J Schanin, KM Coyle, M Butuci, T Luu, EC Brock, A Xu, ...
Frontiers in immunology 12, 650331, 2021
Hide-and-seek: the interplay between cancer stem cells and the immune system
M Sultan, KM Coyle, D Vidovic, ML Thomas, S Gujar, P Marcato
Carcinogenesis 38 (2), 107-118, 2017
Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model
EG Mathenge, CA Dean, D Clements, A Vaghar-Kashani, S Photopoulos, ...
Neoplasia 16 (11), 950-960, 2014
Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3
ML Thomas, R De Antueno, KM Coyle, M Sultan, BM Cruickshank, ...
Molecular oncology 10 (9), 1485-1496, 2016
ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells
D Vidovic, TT Huynh, P Konda, C Dean, BM Cruickshank, M Sultan, ...
Cell Death & Differentiation 27 (1), 363-378, 2020
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma
CK Rushton, SE Arthur, M Alcaide, M Cheung, A Jiang, KM Coyle, ...
Blood advances 4 (13), 2886-2898, 2020
Genetic mutations and epigenetic modifications: driving cancer and informing precision medicine
KM Coyle, JE Boudreau, P Marcato
BioMed research international 2017, 2017
Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing
P Pararajalingam, KM Coyle, SE Arthur, N Thomas, M Alcaide, ...
Blood, The Journal of the American Society of Hematology 136 (5), 572-584, 2020
Epigenetic Silencing of TAP1 in Aldefluor+ Breast Cancer Stem Cells Contributes to Their Enhanced Immune Evasion
M Sultan, D Vidovic, AS Paine, TT Huynh, KM Coyle, ML Thomas, ...
Stem Cells 36 (5), 641-654, 2018
Chemoresistance in cancer stem cells and strategies to overcome resistance
ML Thomas, KM Coyle, M Sultan, A Vaghar-Kashani, P Marcato
Chemotherapy 3 (125), 2, 2014
Newly recruited CD11b+, GR-1+, Ly6Chigh myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus
DR Clements, AM Sterea, Y Kim, E Helson, CA Dean, A Nunokawa, ...
The Journal of Immunology 194 (9), 4397-4412, 2015
Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1
KM Coyle, JP Murphy, D Vidovic, A Vaghar-Kashani, CA Dean, M Sultan, ...
Oncotarget 7 (28), 44096, 2016
Phthalate esters affect maturation and function of primate testis tissue ectopically grafted in mice
JR Rodriguez-Sosa, A Bondareva, L Tang, GF Avelar, KM Coyle, ...
Molecular and cellular endocrinology 398 (1-2), 89-100, 2014
Retinoid signaling in cancer and its promise for therapy
KM Coyle, M Sultan, ML Thomas, A Vaghar-Kashani, P Marcato
J Carcinog Mutagen S 7, 16-18, 2013
Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression
KM Coyle, S Maxwell, ML Thomas, P Marcato
Scientific Reports 7 (1), 16684, 2017
DNA methylation predicts the response of triple-negative breast cancers to all-trans retinoic acid
KM Coyle, CA Dean, ML Thomas, D Vidovic, CA Giacomantonio, L Helyer, ...
Cancers 10 (11), 397, 2018
Phloridzin docosahexaenoate, a novel fatty acid ester of a plant polyphenol, inhibits mammary carcinoma cell metastasis
W Fernando, K Coyle, P Marcato, HPV Rupasinghe, DW Hoskin
Cancer letters 465, 68-81, 2019
Decitabine response in breast cancer requires efficient drug processing and is not limited by multidrug resistance
ML Dahn, BM Cruickshank, AJ Jackson, C Dean, RW Holloway, SR Hall, ...
Molecular Cancer Therapeutics 19 (5), 1110-1122, 2020
The system can't perform the operation now. Try again later.
Articles 1–20